Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.65 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | ERN1 | O75460 | 11/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7094408 | 0.91 | CDK1 (0.65) | CDK1TRPA1ERN1KDM4EUSP2 | |
| SCHEMBL29953951 | 0.85 | CDK1 (0.71) | CDK1ERN1GAANT5EPOLB | |
| SCHEMBL304505 | 0.85 | CDK1 (0.71) | CDK1ERN1GAANT5EPOLB | |
| SCHEMBL1527080 | 0.84 | TRPA1 (0.57) | CDK1TRPA1KDM4EUSP2ALDH1A1 | |
| SCHEMBL1276254 | 0.84 | CDK1 (0.51) | CDK1TRPA1ERN1KDM4EUSP2 | |
| SCHEMBL283097 | 0.83 | CDK1 (0.69) | CDK1ERN1NT5ETRIM24TRIM33 | |
| SCHEMBL19757236 | 0.83 | CDK1 (0.81) | CDK1ERN1ALOX15NT5ETRIM24 | |
| SCHEMBL305915 | 0.82 | CDK1 (0.77) | CDK1ERN1ALDH1A1ALOX15HTT | |
| SCHEMBL29657596 | 0.82 | CDK1 (0.67) | CDK1ERN1NT5ETRIM24TRIM33 | |
| SCHEMBL5528390 | 0.82 | CDK1 (0.67) | CDK1ERN1NT5ETRIM24TRIM33 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4587669-B2 | — | — | 2010-11-24 | — | — | JP | claimed |
| JP-2005509662-A | — | — | 2005-04-14 | — | — | JP | claimed |
| CN-1589136-A | Pharmaceutical and cosmetic compositions containing aromatic aldehydes bearing oxygen-containing groups | CUTANIX CORP (US) | 2005-03-02 | — | — | CN | claimed |
| EP-1443915-A1 | PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES | Cutanix Corporation (US) | 2004-08-11 | — | — | EP | claimed |
| US-20030157154-A1 | Compositions containing hydroxy aromatic aldehydes and their use in treatments | CUTANIX CORPORATION | 2003-08-21 | — | — | US | claimed |
| WO-2003043621-A1 | PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING OXY GROUP-BEARING AROMATIC ALDEHYDES | CUTANIX CORPORATION (US) | 2003-05-30 | — | — | WO | claimed |
| EP-0721482-B1 | ADHESION PROMOTER FOR PVC COMPOUNDS | DU PONT (US) | 1997-11-05 | — | — | EP | claimed |
| EP-0378265-B1 | Low-temperature curable compositions based upon polyaromatic aldehyde group-containing compounds and ketiminized polyamino compounds | AKZO NOBEL NV (NL) | 1994-06-08 | — | — | EP | claimed |
| US-5219954-A | Improved ductility, flexural stiffness, modulus and tensile strength | SHELL OIL COMPANY (US) | 1993-06-15 | — | — | US | claimed |
| CN-121181505-A | Preparation method of 5-ethylbenzofuran-3-carboxylic acid | 凯美克(上海)医药科技有限公司 | 2025-12-23 | — | — | CN | disclosed |
| CN-115710228-B | Pyrazole benzophenone compound and preparation method and application thereof | 江西科技师范大学 | 2024-12-13 | — | — | CN | disclosed |
| US-20230129381-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF ANTICANCER-DRUG RESISTANT CANCERS | THE GEORGE WASHINGTON UNIVERSITY | 2023-04-27 | — | — | US | disclosed |
| CN-115710228-A | Pyrazole benzophenone compound and preparation method and application thereof | 江西科技师范大学 | 2023-02-24 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| CN-1044474-A | Composition based on the low-temperature curable of the polyamino compound of compound that contains many aromatic aldehydes base and ketoimineization | AKZO NV (NL) | 1990-08-08 | — | — | CN | disclosed |
| EP-0378265-A1 | Low-temperature curable compositions based upon polyaromatic aldehyde group-containing compounds and ketiminized polyamino compounds | Akzo Nobel N.V. (NL) | 1990-07-18 | — | — | EP | disclosed |
| WO-1983000333-A1 | ANTI-HYPERTENSOR, HETEROCYCLICALLY DI-ORTHOSUBSTITUTED PHENOLS | TEULON, JEAN-MARIE | 1983-02-03 | — | — | WO | disclosed |
| EP-0070779-A2 | Di-ortho-substituted phenols of which one of the substitutions is a heterocycle, process for their preparation, anti-hypertensive medicines containing them and synthesis intermediates | CARPIBEM (CENTRE D'ACTIVITE ET DE RECHERCHE PHARMACEUTIQUE INDUSTRIELLE BIOLOGIQUE ET MEDICALE) Société Anonyme dite: (FR) | 1983-01-26 | — | — | EP | disclosed |
| US-4002423-A | Benzofuran derivatives process for their preparation and their use as optical brighteners | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-01-11 | — | — | US | disclosed |
| US-3976663-A | INSECTICIDE | THE PROCTER & GAMBLE COMPANY (US) | 1976-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030157154-A1 | Compositions containing hydroxy aromatic aldehydes and their use in treatments | TYR, HRH1, HRH2 | CDK1 4235/4885TRPA1 67/4885ERN1 4830/4885 |
| US-20230129381-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF ANTICANCER-DRUG RESISTANT CANCERS | TP53, ANXA5, MCL1 | CDK1 586/4885TRPA1 4652/4885ERN1 1611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.